Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.74    0.13 (8.07%)
Bid:
1.61
Ask:
1.75
Spread: 0.14 (8.696%)
Market Cap: £34.91m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Valkor update

12 Jun 2026 07:00

RNS Number : 0182I
Quadrise PLC
12 June 2026
 

 

12 June 2026

Quadrise Plc ("Quadrise" or the "Company")

 

Valkor update

Quadrise Plc (AIM: QED), the technology company focused on the decarbonisation of shipping and heavy industry through deployment of low emission fuels and biofuels, provides an update on its project with Valkor Technologies LLC ("Valkor") in Utah, USA.

Progress with Valkor continues to be made towards pilot deployment and the commercial demonstration of the Company's upstream production model. The Quadrise equipment is ready for deployment and the Company has been informed that representative heavy sweet oil samples have been prepared in Valkor's new pilot plant ahead of MSAR® and bioMSAR™ formulation work.

Valkor's 500 barrel per day oil-sands pilot plant is now due to be commissioned in Q4 2026. The Company will not therefore deliver a 600 bpd Multifuel Manufacturing Unit ("MMU") to site by 30 June 2026 as had been previously indicated, this will now take place during Q3 2026.

Since the Company's announcement of 28 November 2025, no further licence fee payments have been received by the Company and US$0.95 million of the US$1.0 million licence fee payable to the Company by Valkor remains outstanding as Valkor await receipt of approved project funding. The Board now expects payment of the licence fee in full by 30 September 2026.

 

For further information please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Peter Borup, Chief Executive Officer

Jason Miles, Chief Technology Officer

 

 

Nominated Adviser

Cavendish Capital Markets Limited

 

 

+44 (0)20 7220 0500

Ben Jeynes

George Lawson

 

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Harry Davies-Ball (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

 

 

+44 (0)20 3005 5000

 

Public & Investor Relations

 

Tavistock Communications (Financial PR & IR)

Simon Hudson

Nick Elwes

Saskia Sizen

 

+44 (0) 20 7920 3150

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global shipping, power generation, industrial and refining industries. Learn more at: www.quadrise.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDFLFFQQLXBBK
Date   Source Headline
26th Mar 20157:00 amRNSNotice of Full Year Results
26th Mar 20157:00 amRNSSignificant holding in Company
19th Mar 20154:30 pmRNSDirector Declaration
19th Mar 20154:30 pmRNSDirector Declaration
10th Mar 201510:00 amRNSDirectors' Shareholdings
9th Mar 20154:30 pmRNSSignificant holding in Company
3rd Mar 20154:31 pmRNSTotal Voting Rights
3rd Mar 20154:30 pmRNSDirector Shareholding
13th Feb 20157:00 amRNSQ3 Trading Update
10th Feb 20154:30 pmRNSDirectors' Shareholdings
3rd Feb 20154:30 pmRNSDirector Shareholding
3rd Feb 20154:30 pmRNSTotal Voting Rights
21st Jan 20157:00 amRNSAppointment of Finance Director
16th Jan 20154:30 pmRNSHolding(s) in Company
7th Jan 20154:30 pmRNSDirector/PDMR Shareholding
5th Jan 20154:31 pmRNSTotal Voting Rights
5th Jan 20154:30 pmRNSDirector/PDMR Shareholding
10th Dec 20144:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20144:31 pmRNSBlocklisting Interim Review
2nd Dec 20144:30 pmRNSTotal Voting Rights
2nd Dec 20144:30 pmRNSDirector/PDMR Shareholding
25th Nov 20147:00 amRNSInterim Results
10th Nov 20144:30 pmRNSDirector/PDMR Shareholding
4th Nov 20144:31 pmRNSTotal Voting Rights
4th Nov 20144:30 pmRNSDirector/PDMR Shareholding
28th Oct 20144:30 pmRNSHolding(s) in Company
28th Oct 201412:53 pmRNSNotice of Interim Results
8th Oct 20144:30 pmRNSDirector/PDMR Shareholding
7th Oct 20147:00 amRNSAnnouncement re: Board Announcement
3rd Oct 20149:31 amRNSTotal Voting Rights
3rd Oct 20149:30 amRNSDirector/PDMR Shareholding
15th Sep 201410:45 amRNSDirector/PDMR Shareholding
10th Sep 20144:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20144:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20144:30 pmRNSHolding(s) in Company
2nd Sep 20144:30 pmRNSTotal Voting Rights
22nd Aug 20144:30 pmRNSAudit Tender Outcome
8th Aug 20147:00 amRNSInterim Management Statement
7th Aug 20144:30 pmRNSDirector/PDMR Shareholding
4th Aug 20144:30 pmRNSDirector/PDMR Shareholding
4th Aug 20144:30 pmRNSTotal Voting Rights
4th Aug 20144:30 pmRNSChange of Registered Office
23rd Jul 20144:30 pmRNSHolding(s) in Company
22nd Jul 20145:29 pmRNSResult of AGM
21st Jul 20145:46 pmRNSAGM Statement
8th Jul 20145:12 pmRNSDirector/PDMR Shareholding
3rd Jul 20144:30 pmRNSHolding(s) in Company
2nd Jul 20144:30 pmRNSDirector/PDMR Shareholding
2nd Jul 20144:30 pmRNSTotal Voting Rights
30th Jun 20144:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.